Stay updated on Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 was added and v3.2.0 was removed in the record history. This appears to be an administrative version update rather than content changes.
    Difference
    0.1%
    Check dated 2025-11-24T21:33:08.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Notice banner about government funding and operating status was removed from the page. The page now presents the study history without this banner.
    Difference
    0.8%
    Check dated 2025-11-17T19:22:46.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Record History shows several updates to Study Status and Recruitment Status across multiple versions, reflecting changes in the trial’s progress. These entries capture core details about the trial’s current and past activity.
    Difference
    0.1%
    Check dated 2025-11-03T13:45:05.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Updates introduce a new version (v3.2.0) and a government-operating status notice regarding NIH Clinical Center operations, replacing the previous v3.1.0 reference.
    Difference
    13%
    Check dated 2025-10-06T02:15:37.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.3%
    Check dated 2025-09-28T23:26:12.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. Additionally, the 'Back to Top' element was removed, with no changes to core content, pricing, stock, or time slot availability.
    Difference
    0.8%
    Check dated 2025-09-14T09:54:01.000Z thumbnail image

Stay in the know with updates to Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.